Phathom Pharmaceuticals (PHAT) Prepaid Assets (2018 - 2026)
Phathom Pharmaceuticals' (PHAT) quarterly Prepaid Assets came in at $8.4 million in Q1 2026, down 35.39% year-on-year from $13.1 million in Q1 2025, and down 45.06% on a QoQ basis from $15.4 million in Q4 2025.
Phathom Pharmaceuticals (PHAT) Prepaid Assets (2018 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has 9 years of Prepaid Assets data on file, last reported at $8.4 million in Q1 2026.
- On a quarterly basis, Prepaid Assets fell 35.39% year-over-year to $8.4 million in Q1 2026; TTM through Mar 2026 was $8.4 million, a 35.39% decrease from a year earlier, with the FY2025 full-year figure at $15.4 million, down 26.42% from the prior year.
- Prepaid Assets for Q1 2026 stood at $8.4 million, down from $15.4 million in the prior quarter.
- Over the last five years, Prepaid Assets for PHAT reached as high as $20.9 million in Q4 2024 and fell as low as $975000.0 in Q3 2022.
- Historically, Prepaid Assets has averaged $11.2 million across 5 years, with a median of $12.9 million in 2023.
- Across the five-year window, Prepaid Assets soared 1226.97% in 2023 and slumped 35.39% in 2026, its largest moves.
- Year by year, Prepaid Assets stood at $5.1 million in 2022, then surged by 157.34% to $13.2 million in 2023, then surged by 58.15% to $20.9 million in 2024, then slipped by 26.42% to $15.4 million in 2025, then slumped by 45.06% to $8.4 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $8.4 million in Q1 2026, $15.4 million in Q4 2025, and $13.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Phathom Pharmaceuticals | 951.79 Mn | 768.02 Mn | 46.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.44 Mn |
| Dec 31, 2025 | 15.35 Mn |
| Sep 30, 2025 | 13.23 Mn |
| Jun 30, 2025 | 14.62 Mn |
| Mar 31, 2025 | 13.06 Mn |
| Dec 31, 2024 | 20.87 Mn |
| Sep 30, 2024 | 14.98 Mn |
| Jun 30, 2024 | 15.50 Mn |
| Mar 31, 2024 | 12.75 Mn |
| Dec 31, 2023 | 13.19 Mn |
| Sep 30, 2023 | 12.94 Mn |
| Jun 30, 2023 | 8.76 Mn |
| Mar 31, 2023 | 10.27 Mn |
| Dec 31, 2022 | 5.13 Mn |
| Sep 30, 2022 | 975,000.00 |
| Jun 30, 2022 | 1.87 Mn |
| Mar 31, 2022 | 7.65 Mn |
| Dec 31, 2021 | 3.27 Mn |
| Sep 30, 2021 | 695,000.00 |
| Jun 30, 2021 | 1.67 Mn |